The CRISPR and Cas Gene Market is redefining the landscape of genetic research and therapeutic development by enabling precise, efficient, and cost-effective gene editing. CRISPR-Cas technology has rapidly transitioned from a laboratory research tool to a cornerstone of next-generation medicine, agriculture, and biotechnology. Valued at US$ 4,899.43 million in 2024, the market is projected to...
Turkish 
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt